The Importance of Strategic Planning for Long-term Training Success
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
CAR T Manufacturing and Toxicity
CAR T Manufacturing and Toxicity Pre-Clinical Considerations Genetically engineered therapeutics present diverse, and sometimes heightened, risks compared to traditional small
Inside Study Activation: Budgeting Takeaways
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Striking the Balance: Ethics, Inclusion, and Vulnerability in Research
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
DSMB Best Practices and Behind the Scenes Insights
Ensure your DSMB meets regulatory standards. Learn best practices in administration, member selection, and overcoming challenges in clinical trial oversight.
Navigating sIRB Complexities: An Interactive Session
Got questions about sIRBs? Join experts as they share insights and priorities, plus a Q&A to address common concerns and your live questions.
Sponsors: Are Your Sites Ready for an FDA Inspection?
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
sIRB Review for Multicenter Research: A Guide for Institutions
Prepare for single IRB review with insights on reliance agreements, communication plans, lead site responsibilities, and technology needs.
How to Improve Your Site Compliance
In this ebook we discuss Break down the most common site violations, and reasons for protocol deviation and Discuss tactics and strategies to help your site team overcome these common challenges.
How Genetic Engineering Will Move Rare Disease Research at Warp Speed
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Trend Report: DE&I in Clinical Research: Where we are Today
Explore the state of DE&I in clinical research with survey insights on diversity plans, budgeting efforts, and progress in trial representation.
Turbocharging Clinical Trial Activation Timelines
Streamlining clinical trial activation requires balancing budgets, approvals, and feasibility—all while accelerating timelines to meet key goals.